A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer
一项 II 期临床试验评估了 BCL-2 同源结构域 3 模拟物 AT-101 联合多西他赛治疗复发性、局部晚期或转移性头颈癌的疗效。
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-016-0364-5
Swiecicki, Paul L; Bellile, Emily; Sacco, Assuntina G; Pearson, Alexander T; Taylor, Jeremy M G; Jackson, Trachette L; Chepeha, Douglas B; Spector, Matthew E; Shuman, Andrew; Malloy, Kelly; Moyer, Jeffrey; McKean, Erin; McLean, Scott; Sukari, Ammar; Wolf, Gregory T; Eisbruch, Avraham; Prince, Mark; Bradford, Carol; Carey, Thomas E; Wang, Shaomeng; Nör, Jacques E; Worden, Francis P
